No abstract available
Keywords:
COVID-19; appropriateness; biomarkers; cost saving; environmental cost; hazardous waste; laboratory.
MeSH terms
-
Biomarkers / blood
-
COVID-19 / diagnosis*
-
COVID-19 / therapy
-
COVID-19 / virology
-
COVID-19 Testing / economics*
-
COVID-19 Testing / instrumentation
-
COVID-19 Testing / methods
-
Cost-Benefit Analysis
-
Hazardous Waste / economics
-
Hazardous Waste / prevention & control*
-
Humans
-
Point-of-Care Testing / economics
-
Point-of-Care Testing / organization & administration
-
Practice Guidelines as Topic
-
SARS-CoV-2 / genetics
-
SARS-CoV-2 / immunology
-
SARS-CoV-2 / pathogenicity*
Substances
-
Biomarkers
-
Hazardous Waste